You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Claims for Patent: 10,420,760


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,420,760
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:15/935,776
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,420,760
Patent Claims: 1. A method for induction of local anesthesia prior to performing a diagnostic procedure on, through, or adjacent to a mucous membrane of the nasal cavities of a patient comprising: determining an estimated glomerular filtration rate for a patient; soaking a plurality of absorbent articles in an aqueous solution comprising sodium benzoate, citric acid, and about 4% cocaine hydrochloride, by weight; and contacting at least one of the plurality of absorbent articles with a mucous membrane of the patient for up to about 20 minutes to reduce sensation in a body region of the patient if the estimated glomerular filtration rate ranges from about 15 mL/min./1.73 m.sup.2 to less than about 60 mL/min./1.73 m.sup.2.

2. The method of claim 1, wherein the estimated glomerular filtration rate ranges from about 44 mL/min./1.73 m.sup.2 to less than about 60 mL/min./1.73 m.sup.2.

3. The method of claim 1, wherein the method is not performed more than once in a 24-hour period.

4. The method of claim 1, wherein the aqueous solution further comprises at least one coloring additive.

5. The method of claim 2, wherein the aqueous solution further comprises at least one coloring additive.

6. The method of claim 3, wherein the aqueous solution further comprises at least one coloring additive.

7. The method of claim 1, wherein the diagnostic procedure comprises nasal endoscopy.

8. The method of claim 1, wherein the diagnostic procedure comprises laryngoscopy.

9. The method of claim 1, wherein the diagnostic procedure comprises nasopharyngeal laryngoscopy.

10. The method of claim 1, wherein the diagnostic procedure comprises transnasal esophagoscopy.

11. The method of claim 1, wherein the diagnostic procedure comprises nasal stroboscopy.

12. A method for induction of local anesthesia prior to performing a medical procedure on, through, or adjacent to a mucous membrane of the nasal cavities of a patient comprising: determining an estimated glomerular filtration rate for a patient; soaking a plurality of absorbent articles in an aqueous solution comprising sodium benzoate, citric acid, and about 4% cocaine hydrochloride, by weight; and contacting at least one of the plurality of absorbent articles with a mucous membrane of the patient for up to about 20 minutes to reduce sensation in a body region of the patient if the estimated glomerular filtration rate ranges from about 15 mL/min./1.73 m.sup.2 to less than about 60 mL/min./1.73 m.sup.2.

13. The method of claim 12, wherein the estimated glomerular filtration rate ranges from about 44 mL/min./1.73 m.sup.2 to less than about 60 mL/min./1.73 m.sup.2.

14. The method of claim 12, wherein the method is not performed more than once in a 24-hour period.

15. The method of claim 12, wherein the aqueous solution further comprises at least one coloring additive.

16. The method of claim 13, wherein the aqueous solution further comprises at least one coloring additive.

17. The method of claim 14, wherein the aqueous solution further comprises at least one coloring additive.

18. The method of claim 12, wherein the medical procedure comprises nasal endoscopy.

19. The method of claim 12, wherein the medical procedure comprises laryngoscopy.

20. The method of claim 12, wherein the medical procedure is at least one procedure selected from the group consisting of nasopharyngeal laryngoscopy, nasal laryngoscopy, nasal debridement, intraturbinate methylprednisolone acetate injection, turbinate reduction, transnasal esophagoscopy, sinuplasty, nasal cauterization, stroboscopy, nasal stroboscopy, and polypectomy.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.